Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001
Saint Herblain (France), March 1, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
News
BlackRock partners with Verizon for private 5G network at new state-of-the-art NYC HQ
Marks the first commercial implementation of Verizon Business’ On Site 5G private network solution in…
Cyble Appoints Former Attivo Networks Executive Vivek Kumar Sharma as Regional Sales Director – Strategic Alliances and Partnerships (India and SAARC)
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cyble, an AI-powered, Y Combinator-backed, cyber threat intelligence company that empowers organizations with…
WNC and Movandi Partner to Deliver Innovative Dual-Band 5G mmWave Smart Repeaters
New WNC Single-box Dual-band mmWave Smart Repeaters Powered by Movandi Shipping and Available Today Enables…
Aquestive Therapeutics Presented Positive Topline Phase 1 Results for AQST-109 Epinephrine Oral Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
WARREN, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
CORRECTION – Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — In a release issued under…
Allen Matkins Expands its Land Use Practice with Addition of Partner Jonathan E. Shardlow to its Orange County Office
IRVINE, Calif.–(BUSINESS WIRE)–Allen Matkins, a California-based, full-service real estate and business law firm, announced today…
iCapital® Expands Strategic Partnership With Bank of Singapore
Deal deepens iCapital’s relationship with one of the fastest growing Asian private banks and accelerates…
Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading on the Nasdaq
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (Nasdaq: COSM), an…
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
OTO-313 Phase 2 trial in tinnitus fully enrolled ahead of schedule with top-line results expected…
GENFIT Announces Solid Revenues and Cash Position as of December 31, 2021
Cash and cash equivalents totaled €258.8 million as of December 31, 2021, which includes the…
Vaxcyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
— First Participants Dosed in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of…
Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress
RAS(ON) Inhibitor Pipeline Continues to Advance and Expand, Now Addressing Majority of RAS-Addicted Cancers; Two…
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and…
Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel™ in Fragile X Syndrome
Provides 10-year market exclusivity in EU upon regulatory approval DEVON, Pa., Feb. 28, 2022 (GLOBE…
Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company…
Day One to Participate in the Cowen 42nd Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN),…
Imago BioSciences to Participate in the Cowen 42nd Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…